Arcellx (ACLX) Cash from Financing Activities (2021 - 2025)

Arcellx's (ACLX) quarterly Cash from Financing Activities came in at $1.6 million in Q4 2025, up 127.16% year-on-year from $719328.2 in Q4 2024, and down 98.1% quarter-over-quarter from $86.1 million in Q3 2025.

Arcellx (ACLX) Cash from Financing Activities (2021 - 2025) Analysis & Trends

Arcellx's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 127.16% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $98.5 million, a 509.08% increase from a year earlier, with the FY2025 full-year figure at $98.5 million, up 509.08% from the prior year.
  • Cash from Financing Activities eased to $1.6 million in Q4 2025 per ACLX's latest filing, from $86.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $188.6 million in Q4 2023 and bottomed at -$10.4 million in Q2 2024.
  • The 5-year median for Cash from Financing Activities is $928500.0 (2022), against an average of $36.2 million.
  • Across the five-year window, Cash from Financing Activities jumped 14252.44% in 2023 and slumped 9088.79% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $15000.0 in 2021, then surged by 8660.0% to $1.3 million in 2022, then soared by 14252.44% to $188.6 million in 2023, then tumbled by 103.19% to -$6.0 million in 2024, then surged by 127.16% to $1.6 million in 2025.
  • Per Business Quant, the three latest ACLX Cash from Financing Activities figures stand at $1.6 million (Q4 2025), $86.1 million (Q3 2025), and $10.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 1.63 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.63 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 86.10 Mn
Sep 30, 2025 86.10 Mn
Jun 30, 2025 10.26 Mn
Jun 30, 2025 10.26 Mn
Mar 31, 2025 543,000.00
Mar 31, 2025 543,000.00
Dec 31, 2024 -6.02 Mn
Dec 31, 2024 -6.02 Mn
Sep 30, 2024 -4.66 Mn
Sep 30, 2024 -4.66 Mn
Jun 30, 2024 -10.43 Mn
Jun 30, 2024 -10.43 Mn
Mar 31, 2024 -2.99 Mn
Mar 31, 2024 -2.99 Mn
Dec 31, 2023 188.59 Mn
Dec 31, 2023 188.59 Mn
Sep 30, 2023 -4.99 Mn
Sep 30, 2023 -4.99 Mn